Author:
Mastria Eric M.,Lokken R. Peter,Lehrman Evan D.
Publisher
Springer International Publishing
Reference79 articles.
1. Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–93.
2. TheraSphere™ Yttrium-90 Glass Microspheres Instructions for Use [Internet]. Boston Scientific. https://www.bostonscientific.com/content/dam/elabeling/pi/OTT-00221_Rev1_TheraSphere_en_s.pdf
3. SIR-Spheres® Y-90 resin microspheres Instructions for Use [Internet]. Sirtex Medical. https://www.sirtex.com/media/55rprxv2/ssl-us-14-sir-spheres-microspheres-ifu-us.pdf
4. Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2011;38(7):1393–406.
5. Pieper CC, Willinek WA, Thomas D, Ahmadzadehfar H, Essler M, Nadal J, et al. Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis. Eur Radiol. 2016;26(8):2779–89.